These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


561 related items for PubMed ID: 29213007

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Use of BI-RADS-MRI descriptors for differentiation between mucinous carcinoma and fibroadenoma.
    Igarashi T, Ashida H, Morikawa K, Motohashi K, Fukuda K.
    Eur J Radiol; 2016 Jun; 85(6):1092-8. PubMed ID: 27161057
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A pilot study to determine the diagnostic criteria of spiculated masses for BI-RADS MRI category 5: when to perform re-biopsy after discordant pathologic result?
    Onishi N, Kataoka M, Kanao S, Kawai M, Iima M, Ohashi A, Toi M, Togashi K.
    Breast Cancer; 2017 Jan; 24(1):69-78. PubMed ID: 26832858
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Apparent Diffusion Coefficient to Subdivide Breast Imaging Reporting and Data System Magnetic Resonance Imaging (BI-RADS-MRI) Category 4 Lesions.
    Liu D, Ba Z, Ni X, Wang L, Yu D, Ma X.
    Med Sci Monit; 2018 Apr 12; 24():2180-2188. PubMed ID: 29644993
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size.
    Partridge SC, Mullins CD, Kurland BF, Allain MD, DeMartini WB, Eby PR, Lehman CD.
    AJR Am J Roentgenol; 2010 Jun 12; 194(6):1664-73. PubMed ID: 20489111
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Predictive value for malignancy of suspicious breast masses of BI-RADS categories 4 and 5 using ultrasound elastography and MR diffusion-weighted imaging.
    Satake H, Nishio A, Ikeda M, Ishigaki S, Shimamoto K, Hirano M, Naganawa S.
    AJR Am J Roentgenol; 2011 Jan 12; 196(1):202-9. PubMed ID: 21178068
    [Abstract] [Full Text] [Related]

  • 17. Combining b2500 diffusion-weighted imaging with BI-RADS improves the specificity of breast MRI.
    Saccenti L, Mellon CM, Scholer M, Jolibois Z, Stemmer A, Weiland E, de Bazelaire C.
    Diagn Interv Imaging; 2023 Sep 12; 104(9):410-418. PubMed ID: 37208291
    [Abstract] [Full Text] [Related]

  • 18. Incorporating diffusion-weighted imaging in a diagnostic algorithm for multiparametric MR mammography.
    Vassiou K, Fanariotis M, Tsougos I, Fezoulidis I.
    Acta Radiol; 2022 Oct 12; 63(10):1332-1343. PubMed ID: 34605311
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
    Liu Y, Wang S, Qu J, Tang R, Wang C, Xiao F, Pang P, Sun Z, Xu M, Li J.
    BMC Med Imaging; 2023 Apr 19; 23(1):58. PubMed ID: 37076817
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.